MediPharm Labs (STU:MLZ) COGS-to-Revenue : 0.73 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs COGS-to-Revenue?

MediPharm Labs's Cost of Goods Sold for the three months ended in Mar. 2024 was €4.84 Mil. Its Revenue for the three months ended in Mar. 2024 was €6.64 Mil.

MediPharm Labs's COGS to Revenue for the three months ended in Mar. 2024 was 0.73.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. MediPharm Labs's Gross Margin % for the three months ended in Mar. 2024 was 27.13%.

MediPharm Labs COGS-to-Revenue Historical Data

The historical data trend for MediPharm Labs's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs COGS-to-Revenue Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.67

2.22

1.70

1.09

0.82

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.93	0.91	0.72	0.76	0.73

MediPharm Labs COGS-to-Revenue Calculation

MediPharm Labs's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	18.596	/	22.598
	=	0.82

MediPharm Labs's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.839	/	6.641
	=	0.73

MediPharm Labs (STU:MLZ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

MediPharm Labs's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4.839 / 6.641
	=	27.13 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

MediPharm Labs COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (STU:MLZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines